Ocean Biomedical Files 2024 10-K

Ticker: OCEA · Form: 10-K · Filed: Apr 8, 2025 · CIK: 1869974

Sentiment: neutral

Topics: 10-K, pharmaceuticals, financials

TL;DR

OCEA 10-K filed: full year 2024 financials out. Check for biz updates.

AI Summary

Ocean Biomedical, Inc. filed its 2024 10-K on April 8, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Aesther Healthcare Acquisition Corp., is involved in the pharmaceutical preparations industry. Its business address is located at 515 Madison Ave, Suite 8078, New York, NY 10022.

Why It Matters

This filing provides investors and the public with a comprehensive overview of Ocean Biomedical's financial performance, strategic direction, and risk factors for the fiscal year 2024.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, Ocean Biomedical faces inherent risks related to drug development, regulatory approvals, and market competition.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of Ocean Biomedical, Inc.?

Ocean Biomedical, Inc. is classified under the Pharmaceutical Preparations industry (SIC code 2834).

When did Ocean Biomedical, Inc. change its name from Aesther Healthcare Acquisition Corp.?

The company's name change from Aesther Healthcare Acquisition Corp. to Ocean Biomedical, Inc. occurred on February 14, 2023.

What is the business address of Ocean Biomedical, Inc.?

The business address is 515 Madison Ave, Suite 8078, New York, NY 10022.

What is the SEC file number for Ocean Biomedical, Inc.?

The SEC file number is 001-40793.

What is the par value of Ocean Biomedical's common stock?

The par value of Ocean Biomedical's common stock is $0.0001 per share.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on April 8, 2025 regarding Ocean Biomedical, Inc. (OCEA).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing